These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31614038)

  • 1. Secukinumab for psoriasis in a patient with familial Mediterranean fever.
    Cannavò SP; Papaianni V; Bartolotta A; Guarneri C
    Dermatol Ther; 2019 Nov; 32(6):e13122. PubMed ID: 31614038
    [No Abstract]   [Full Text] [Related]  

  • 2. Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years.
    Reich K; Blauvelt A; Armstrong A; Langley RG; de Vera A; Kolbinger F; Spindeldreher S; Ren M; Bruin G
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1733-1741. PubMed ID: 31009130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Body Weight on Risk-Benefit and Dosing Regimen Recommendation of Secukinumab for the Treatment of Moderate to Severe Plaque Psoriasis.
    Lee JE; Wang J; Florian J; Wang YM; Kettl D; Marcus K; Woitach A
    Clin Pharmacol Ther; 2019 Jul; 106(1):78-80. PubMed ID: 31188469
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Use of Secukinumab in Various Scenarios of Psoriasis.
    Chhabra G; Verma P; Khunger N
    Skinmed; 2020; 18(5):274-276. PubMed ID: 33160436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secukinumab survival and long-term efficacy in patients with plaque psoriasis: real-life data from a tertiary hospital in Greece.
    Sotiriou E; Tsentemeidou A; Vakirlis E; Sideris N; Ioannides D
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):e82-e84. PubMed ID: 30176180
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical outcomes in patients on secukinumab (Cosentyx
    Sears AV; Szlumper C; Liu KW; Smith CH; Barker JNWN; Pink AE
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):e89-e91. PubMed ID: 30198598
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to ixekizumab in a patient of psoriasis with secondary failure to secukinumab.
    Mittal S
    Indian J Dermatol Venereol Leprol; 2021; 87(1):119-121. PubMed ID: 33037161
    [No Abstract]   [Full Text] [Related]  

  • 8. The successful treatment with ixekizumab in a multi-failure psoriasis patient.
    Azevedo A; Torres T
    Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic early improvement of psoriasis in an 11-year old boy after four doses of secukinumab following an alternative dosing scheme.
    Hoff J; Spora L; Fang Y; Brüggen MC; Möhrenschlager M
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e399-e400. PubMed ID: 37909322
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti IL-17 flared psoriasis in a patient on secukinumab.
    Noell C; McQuade B; Gottlieb A; Rosmarin D
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28547879
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.
    Conti A; Peccerillo F; Amerio P; Balato A; Bardazzi F; Bianchi L; Burlando M; Cannavò SP; Chiricozzi A; Dapavo P; De Simone C; Fargnoli MC; Gambardella A; Gisondi P; Malagoli P; Malara G; Mugheddu C; Offidani AM; Piaserico S; Prignano F; Stingeni L; Pellacani G
    Br J Dermatol; 2019 Jun; 180(6):1547-1548. PubMed ID: 30578668
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of ixekizumab in patients with resistance or incomplete response to secukinumab.
    Hegazy S; Konstantinou MP; Bulai Livideanu C; Tauber M; Paul C
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):e338-e341. PubMed ID: 31001858
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-life efficacy and safety of secukinumab: results from a tertiary hospital in Greece.
    Tsentemeidou A; Sotiriou E; Vakirlis E; Sideris N; Papadimitriou I; Lazaridou E; Ioannides D
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):e50-e51. PubMed ID: 29959803
    [No Abstract]   [Full Text] [Related]  

  • 14. Intramatricial low-dose secukinumab injection for nail psoriasis.
    He F; Long F; Tu J; Yin Z
    Indian J Dermatol Venereol Leprol; 2021; 87(1):116-119. PubMed ID: 32930105
    [No Abstract]   [Full Text] [Related]  

  • 15. Mild therapeutic response of alopecia areata during treatment of psoriasis with secukinumab.
    Pagnanelli G; Cavani A; Canzona F; Mazzanti C
    Eur J Dermatol; 2020 Oct; 30(5):602-603. PubMed ID: 33185532
    [No Abstract]   [Full Text] [Related]  

  • 16. First emergence of pyoderma gangraenosum, palmoplantar pustulosis and sacroiliitis in a psoriasis patient associated with switching from secukinumab to brodalumab.
    Sadik CD; Thieme M; Zillikens D; Terheyden P
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e406-e407. PubMed ID: 31131924
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever.
    Unal Enginar A; Gundogdu M
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):19-21. PubMed ID: 34508267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance.
    Ferrières L; Konstantinou MP; Bulai Livideanu C; Hegazy S; Tauber M; Amelot F; Paul C
    Clin Exp Dermatol; 2019 Oct; 44(7):e230-e234. PubMed ID: 31055846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 inhibitors for psoriasis.
    Paek SY; Frieder J; Kivelevitch D; Menter MA
    Semin Cutan Med Surg; 2018 Sep; 37(3):148-157. PubMed ID: 30215631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of 22 psoriatic patients treated with ixekizumab after failure of secukinumab.
    Amschler K; Phillip S; Mohr J; Wilsmann-Theis D; Poortinga S; Gerdes S; Mössner R
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.